From transplant to novel cellular therapies in multiple myeloma: European Myeloma Network guidelines and future perspectives

Survival of myeloma patients has greatly improved with the use of autologous stem cell transplantation and novel agents, such as proteasome inhibitors, immunomodulatory drugs and monoclonal antibodies. Compared to bortezomib- and lenalidomide-based regimens alone, the addition of high-dose melphalan...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Haematologica
Autors principals: Gay, Francesca, Engelhardt, Monika, Terpos, Evangelos, Wäsch, Ralph, Giaccone, Luisa, Auner, Holger W., Caers, Jo, Gramatzki, Martin, van de Donk, Niels, Oliva, Stefania, Zamagni, Elena, Garderet, Laurent, Straka, Christian, Hajek, Roman, Ludwig, Heinz, Einsele, Herman, Dimopoulos, Meletios, Boccadoro, Mario, Kröger, Nicolaus, Cavo, Michele, Goldschmidt, Hartmut, Bruno, Benedetto, Sonneveld, Pieter
Format: Artigo
Idioma:Inglês
Publicat: Ferrata Storti Foundation 2018
Matèries:
Review Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5792264/
https://ncbi.nlm.nih.gov/pubmed/29217780
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2017.174573
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars